chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up screaming, fever of 102.7, screamed for over 1 hour, both legs were red, swollen and hot to the touch.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 02-DEC-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, 0.5 ml, (lot # K009105, expiration date 21-JAN-2016) (route and dose were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for each time were 144, 31 and R; 48, 34 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case reported by a nurse, describes the occurrence of administered expired product (expired vaccine administered to patient/dose administered after 30-day use by date/expired lot) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 045B21A) for COVID-19 immunization. Concurrent medical conditions included Type 2 diabetes mellitus and non-alcoholic fatty liver (non-alcoholic cirrhosis). On Oct 15, 2021 at 8:15, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; .5 milliliter. On Oct 15, 2021, patient administered expired product (expired vaccine administered to patient/dose administered after 30-day use by date/expired lot). On Oct 15, 2021, administered expired product (expired vaccine administered to patient/dose administered after 30-day use by date/expired lot) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. Reporter stated patient tolerated vaccine well and no acute distress noted. This case linked to MOD-2021-354279 (patient link). Most recent follow-up information incorporated: On Oct 19, 2021: Follow-up received on  Oct 19, 2021: Patient's demographics and medical history updated.
Sore arm at injection site - beginning 12 hours after injection Swollen and sore lymph nodes under left arm - beginning 30 hours after injection
Pt had booster vaccine  yesterday and started to feel weak and "achy" several hours afterwards. Her  brother also has the vaccine and shared similar "aches," however, brother improved  but Pt did not and her temperature was checked by her grandmother the next  morning. She states she used a temporal thermometer and the Pt's temp first read  105F, she rechecked and her temp was 103F she then took 400mg of Motrin and her  temp is now 98.6. The guardian checked the Pt's O2 via pulse ox and it read 98%  She has significantly improved since last night but she still feels fatigue. She admits to  chills w/0 rigors. She denies any nausea, vomiting, coughing, SOB, loss of taste  or smell. She also denies CP, HA, palpitations. No further complaints.
on 10/2, patient work up with redness and hard knot at injection site. pt complains of numbness in entire arm, including  fingers. I advised her to contact md immediately
Red rash developed at injection site following injection and grew in size. Earlier this year, rash never went away and biopsy conducted and found to be basal cell carcinoma in situ.
I feel bad; I feel like having body aches; I have like flu symptoms, I feel I am low; I have like flu symptoms, I feel I am low; This is a spontaneous report from a contactable consumer (patient).   This patient of unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 29Dec2020 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient reported got the vaccine on 29Dec2020 and thinks got the side (sentence incomplete). The patient felt bad, felt like having body aches until today the patient had like flu symptoms. The patient felt low, the patient doesn't know it's just side effects or just regular flu. Outcome was unknown. Information about lot/batch number has been requested.
Red and pain starting 8/31/18 after lunch. Used ice pack and TYLENOL. Some swelling. Appointment scheduled 9/5/18.
Has not received a second dose yet; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received Shingrix a couple of years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The reporter was patient's neighbor. The age at vaccination was not applicable.  The patient only received one dose of shingrix and had not received a 2nd dose till the time of reporting, which led to incomplete course of vaccination. The reporter did not feel comfortable providing patient's information.  The reporter did not provide the date of birth, initials, lot/exp date, route/date of administration, and consent to follow-up with HCP.  However, the patient received the vaccine at the same Pharmacy that the reporter went to. The reporter consented to follow up. This case was 1 of 3 case reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021264519:Same reporter. US-GLAXOSMITHKLINE-US2021261510:Same reporter.
Tightness of chest, elevated heart rate, muscle and joint aches, fatigue, exhaustion, pain at injection site. No treatment sought as of yet.
Left, underarm, Lymphadenopathy that lasted for 17 days Also enlargement of left breast by about 15%
Gave 2 Moderna vaccines that were from vial that were punctured on 6-19-2-21; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave 2 Moderna vaccines that were from vial that were punctured on 6-19-2-21) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032m20a) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave 2 Moderna vaccines that were from vial that were punctured on 6-19-2-21). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave 2 Moderna vaccines that were from vial that were punctured on 6-19-2-21) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Still feel cold; Upset stomach; Chills, shivering; Stomach ache; Nausea; Fever; Achy; Hot 4 days after shot; This case was reported by a consumer and described the occurrence of feeling cold in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included back surgery (3 months ago).   On 16th November 2022, the patient received the 1st dose of Shingrix. In November 2022, less than a week after receiving Shingrix, the patient experienced feeling cold, upset stomach, shivering, stomach pain, nausea, fever, pain and feeling hot. On an unknown date, the outcome of the feeling cold, upset stomach, shivering, stomach pain, nausea, fever, pain and feeling hot were recovering/resolving.   It was unknown if the reporter considered the feeling cold, upset stomach, shivering, stomach pain, nausea, fever, pain and feeling hot to be related to Shingrix.     Additional Information: GSK Receipt Date: 20-Nov-2022 Reporter's comment: The patient got her shot on Wednesday and still felt cold, upset stomach, achy, hot 4 days after her shot. The patient provided the above address, which was current.  The patient stated that she had acromioclavicular surgery months ago.  The patient received her Shingrix vaccine at her doctor's office.  The patient consented to follow up with health-care professional. The patient had experienced stomach ache, chills, nausea, fever, shivering ever since receiving her first dose of the Shingrix vaccine last week. The symptoms were subsiding.  The call back to the patient was done on 21st November 2022. The consent to follow-up was granted.
This spontaneous report as received from a healthcare worker refers to a 6 months old patient of unknown gender. The patient's relevant medical history, current conditions and concomitant medications were not reported. On 10-NOV-2015 the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) lot # L008053, with an expiry date of 30-NOV-2016, orally. The vaccine was administered at public health clinic or hospital with public funds. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Apart from the expected side effects (headache and chills, some soreness at injection site), I believe I'm experiencing tinnitus or a similar ringing in my ears. It appears to be concentrated in my left ear, although it's hard to tell. There's a consistent high-pitched tone that won't go away. I'm not entirely sure when it started (maybe 24-36 hours after receiving the vaccine), but it's gotten slightly worse since then and is more noticeable. I have not been able to go to the doctor yet.
achy; body hurting all over; flushed face; fever; pain at the injection site; trouble sleeping; feels like she has the flu; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy; body hurting all over), FLUSHING (flushed face), PYREXIA (fever), VACCINATION SITE PAIN (pain at the injection site) and INSOMNIA (trouble sleeping) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MYALGIA (achy; body hurting all over), FLUSHING (flushed face), PYREXIA (fever), VACCINATION SITE PAIN (pain at the injection site), INSOMNIA (trouble sleeping) and INFLUENZA LIKE ILLNESS (feels like she has the flu). At the time of the report, MYALGIA (achy; body hurting all over), FLUSHING (flushed face), PYREXIA (fever), VACCINATION SITE PAIN (pain at the injection site), INSOMNIA (trouble sleeping) and INFLUENZA LIKE ILLNESS (feels like she has the flu) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included Sleeping pills. No concomitant medications were provided by reporter.
first shot a month earlier - sore arm, gland swollen in armpit, very cold & headache.  2nd shot - sore arm, sore back of neck from headache (muscles seemed frozen for days), really cold from 8pm to 4am with debilitating headache.  left side of body was without coordination, hip, knee, ankle didn't work.  Went sideways with all joints when walking. 03/18/2021 - passed out in bathroom due to pain.  Hit door frame and had large lump on forehead.  Bowel mess to clean up.  03/21/2021 - didn't dress, still wobbly stomache upset, neck sore, dizzyness, ate squash and beans.  04/01/2021 - still have stomache upset and though day temperature is over 70 degrees, am very cold, tired as soon as do just one thing. continues
Fever the night after vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 34-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient experienced fever the night after vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event fever the night after vaccine was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient describes large red bump around the size of a coin at site of injection 2 days after receipt. Patient states it is warm to the touch. Pain at injection site. Patient describes no other symptoms a this time. Patient will continue to monitor for possible infection vs localized reaction over coming days. Instructed to seek medical attention if increases in size / pain / or fever. Will follow up with patient.
I have had achiness and fatigue from previous Covid shots, but this shot gave me uncontrollable, involuntary shaking beyond normal chills.  This shaking would last up to 2 hours no matter what I did.  These shaking "spells" would happen about every 4 hours and last 1 1/2 to 2 hours.  When the spell ended, I usually was exhausted and fell asleep.  I would awake drenching from sweat and need to remove the multiple layers of clothing and blankets I had donned to stop the shaking.  The shaking began about 7:30pm on October 4th, occurring about every 4 hours, until the last event at 10:30am on October 6th.  I also found it difficult to consume liquids and keep anything down.
Initial misuse report received on 11 October 2013 from a medical assistant. A 18 months old unknown patient whose gender, medical history and concomitant medications were not reported, received a dose of FLUZONE ID (lot number, route and site of vaccination was not reported) on an unspecified date. It was reported that a patient received the (FLUZONE) ID. As of unknown date, patient used FLUZONE ID vaccine had been administered to an individual whose age falls outside the products indication. Consider reimmunizing the person with an influenza vaccine appropriate for the person age. List of documents held by sender: none.
Received 2nd shot at 10am.  At midnight I started to feel flu-like symptoms coming on:  body aches, fever, upset stomach, headache.  Symptoms progressively became worse overnight and throughout the next day.  Felt slightly better the next morning.  Symptoms subsided slowly througout the next day.  For the following week after the 2nd shot I didn't feel right:  weakness, on/off body aches, headache.    This "vaccine" needs more work, these symptoms shouldn't have happened to me.
nausea, vomiting, bloody diarrhea, abdominal cramping, chills, fatigue started about 24 hours after vaccination. Lasted approx 48 hours.
Muscular tension dysphonia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Jul2022 as dose 4 (booster), single (Lot number: F107135) at the age of 66 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ANASTROZOLE. Vaccination history included: BNT162b2 (dose 1, lot number=EN6207, vaccine location=Right arm), administration date: 12Mar2021, when the patient was 64-year-old, for COVID-19 Immunization; BNT162b2 (dose 2, lot number=ER8734,, vaccine location=Right arm), administration date: 02Apr2021, when the patient was 64-year-old, for COVID-19 Immunization; BNT162b2 (dose 3, lot number=FF2589, vaccine location=Left arm), administration date: 11Oct2021, when the patient was 65-year-old, for COVID-19 Immunization. The patient had no other vaccine in four weeks. The following information was reported: DYSPHONIA (disability) with onset 01Aug2022, outcome "not recovered", described as "Muscular tension dysphonia". The event "muscular tension dysphonia" required physician office visit. Therapeutic measures were not taken as a result of dysphonia.
Pain and redness at injection site on day of injection followed by significant swelling  and redness of elbow on same arm as injection site one day later. Patient reported no pain at elbow but only redness and swelling.
This spontaneous report was received from a pharmacist via a company representative referring to a female patient of unknown age. The patient's concurrent conditions and medical history were not provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (strength, dose, dose number, anatomical location, lot number and expiration date were not provided). No concomitant medication was reported. Later that night, the patient was admitted to an unspecified hospital for an unspecified reason, while at the hospital, the patient was diagnosed with shingles. The patient did not die. No product quality complaint was involved. The outcome of adverse event and herpes zoster was unknown. Additional information has been requested.
Person received the Johnson & Johnson vaccine on 3/4/21 and then received their first Pfizer vaccine on 5/14/21.
This spontaneous report as received from healthcare professional, refers to a female patient onher20's. Medical history and concurrent conditions were not reported. The healthcare professional informed that on an unspecified date in April 2015 the patient was inadvertently vaccinated with ZOSTAVAX (strength, dosage, route lot# and expiration date were not reported), instead of the second dose of VARIVAX. No adverse effects were reported. Additional information has been requested.
I got vaccinated on 3/11. About a week and a half ago from today's date (4/3/2021), I began experiencing spotting of blood. I am currently in the middle of my last 3rd month of 3 month birth control pills, and was not late enough on a pill to trigger spotting. I have had intermittent low and heavy spotting, with some clotting. It fluctuates, sometimes red, sometime brown. It is ongoing, I have just today reported it to my primary care doctor via email but have not heard back from her yet.
severe arthralgias; migraine headache; mild nausea; This is a spontaneous report from a contactable nurse. A 59-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL0142/expiration date unknown) dose number 2, via an unspecified route of administration on 08Jan2021 09:00 at a single dose on the right arm for COVID-19 immunization. The patient received the vaccine in a hospital. Medical history included asthma, arrhythmia, sulfonamide allergy, and latex allergy. The patient was not diagnosed with COVID prior vaccination and was not tested for COVID post vaccination. Historical vaccine included BNT162B2 (COVID-19, lot number EJ1685, dose number 1) on 18Dec2020 06:30 on the right arm. There were no other vaccinations within 4 weeks. Concomitant medications included ASA, acetylsalicylic acid, caffeine, paracetamol, salicylamide (EXCEDRIN), cyanocobalamin (VIT B12), ergocalciferol (VIT D), and cetirizine hydrochloride (ZYRTEK). The patient experienced severe arthralgias, migraine headache, and mild nausea on 08Jan2021 20:00. The outcome of the events was recovered in Jan2021.
Two wks following 3rd dose of vax pt developed urticaria which was chronically recurrent;
pt recv vax & devel inj site rxn characterized by an area of redness, warmth & pain measuring 2-3 inches in diameter, p/vax lot# 4978188;this is 1 of 3  who exp this rxn;
Pt reported to clinic on 7/8/2019.  Pt reports noting ?itchy bumps and spots? all over his body on 7/4/2019.  Pt noted to have lesions of varying sizes on head/neck.  No lesions seen on bilateral upper extremities though patient reports lesions are present on his legs and torso. Pt was initially assessed by his PCM and a dermatologist was consulted.  Pt was treated for nodulocystic acne and will have a follow up appointment with the dermatologist on 7/12/2019.  Additionally, daily dressing changes will be done at the clinic by RN for close monitoring.  Previous vaccination site was covered with telfa dressing and paper tape. Post-smallpox vaccine care instructions reviewed with teach back.
pt states after the booster vax she started feeling bad.  She started having tenderness in her left arm and became nauseated.  The pain spread from her shoulder to her chest.  She began having chest pains and cold sweats so she thought she was having a heart attack.  She called her doctors office and wait it out to see what happens.  The pain became worse and started feeling like she couldn't breath.  She took her asthma medicine and laid down.  She still had chest pains when she would breath in and out.  Her left arm became swollen and she could not lift it.  She took some meloxicam and went to sleep.  When she woke up the pain came back.  She went to see her Doctor and was told she had covid arm.  This pain lasted about 4 or 5 days.  Her heart rate and blood pressure was up but was told nothing else was  wrong.  Her chest pains lasted about 3 days.  She no longer has these symptoms.  She has had an infection in both ears since getting her first Covid vaccine that she still has today.
administering Bexsero instead of Menveo; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old patient who received Men B NVS (Bexsero) (batch number ABXB36AA, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 26th March 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 26th March 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 29-Mar-2022 Reporter's Comments: Association reported potential case of administering Bexsero instead of Menveo. Health care professional (HCP) said that the count of Bexsero and Menveo were off they realized the possible mistake. The reporter consented to follow up. Additional Supportive Information: The patient received Bexsero instead of Menveo, which led to wrong vaccine administered. This is one of 4 cases, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022056731:same reporter US-GLAXOSMITHKLINE-US2022056734:same reporter US-GLAXOSMITHKLINE-US2022056732:same reporter